论文部分内容阅读
2013年度天然药物及仿生药物国家重点实验室学术年会暨关键科学问题研讨会于2014年4月3日在北京唯实大厦召开。张礼和院士、陈凯先院士、詹其敏院士、涂永强院士、周其林院士、蒋建东教授、郝小江教授、马大为教授、娄红祥教授、刘刚教授、谭仁祥教授、朱依谆教授、叶德全教授、席真教授、王一涛教授、杨震教授、叶新山教授等19位实验室学术委员出席会议。北京大学医学部方伟岗副主任、科研处沈如群处长、人事处朱树梅处长、北京大学科研部基地处郑英姿处长、药学院院长刘俊义教授、党委书记徐萍教授等应邀出席会议。实验室课题组组长、科研骨干等90余人参加了会议。3日上午的会议由叶敏教授主持。实验室主任周德敏教授做了工作报告,从实验室总体定位、科研成果、人才培养、基地建设、运行管理、存在问题和措施等较为全面地汇报了2013年实验室的总体进展。此外,有10个课题在会议上进行了实验室重点支持方向的申请答辩。课题负责人详细阐述了申请课题的重要性、拟解决的科学问题、对药物创新的引领性和辐射作用以及工作基础和研究团队等,并接受了与会专家的提问。围绕每一个课题,与会代表与答辩人进行了充分的讨论,并给出了很多建设性意见。
2013 Annual Meeting of State Key Laboratories of Natural Medicine and Biomimetic Drugs and Key Scientific Issues Symposium was held on April 3, 2014 at the only real building in Beijing. Professor Zhang Kaihe, Academician Chen Kai Xian, Academician Zhan Qimin, Academician Tu Yongqiang, Academician Zhou Qilin, Professor Jiang Jindong, Professor Hao Xiaojiang, Professor Ma Dayi, Professor Lou Hongxiang, Professor Liu Gang, Professor Tan Renxiang, Professor Zhu Yizhen, Professor Wang Yitao, Professor Yang Zhen, Professor Ye Xushan and other 19 academic committee attended the meeting. Fang Weigang, deputy director of Peking University Health Science Center, Shen Ruqun, Director of Scientific Research Department, Zhu Shumei, Director of Human Resources Department, Zheng Yingzi, director of Peking University Science Research Department, Professor Liu Junyi, secretary of the School of Pharmacy, and Xu Ping, party secretary, attended the conference. More than 90 labors, team leaders and scientific research cadres attended the conference. The 3rd morning meeting was presided over by Professor Ye Min. Professor Zhou Demin, director of the lab, gave a report on the work of the laboratory in 2013, reporting the overall progress of the laboratory in 2013 from the overall orientation of the laboratory, achievements in scientific research, personnel training, base construction, operation and management, existing problems and measures. In addition, there are 10 subjects at the meeting conducted a laboratory focused on the direction of the defense applications. The person in charge of the project elaborated the importance of the application subject, the scientific problem to be solved, the leading role and radiation effect of the drug innovation, the foundation of the work and the research team, and also took questions from the participating experts. Around each subject, participants and respondents conducted a full discussion, and given a lot of constructive comments.